Literature DB >> 27769900

Extended-spectrum β-lactamase-producing Enterobacteriaceae colonisation in long-term overseas business travellers.

Yasutaka Mizuno1, Yuri Miura2, Tetsuo Yamaguchi3, Tetsuya Matsumoto4.   

Abstract

BACKGROUND: International travel is considered a risk for colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE). To our knowledge, no studies to date have focused on ESBL-PE colonisation among long-term business travellers. Therefore this study aimed to clarify the characteristics associated with ESBL-PE colonisation in Japanese long-term business travellers.
METHODS: Japanese business travellers planning to stay abroad for ≥6 months were enrolled. Of the 192 travellers, 135 provided only post-travel stool samples and 57 provided both pre- and post-travel stool samples. Additionally, microbiological analyses of ESBL-PE strains, including susceptibility tests and polymerase chain reaction amplification of CTX-M genes and their sequencing were performed.
RESULTS: A post-travel survey showed that of the 55 travellers (40.7%) who tested positive for ESBL-PE after travel, the highest proportion was travellers returning from East and Central Asia. CTX-M gene analyses showed that CTX-M-15 was the most frequently observed (55.0%). A pre- and post-travel survey showed that of the 22 travellers (44.9%) acquired ESBL-PE during their travel, with acquisition most frequently observed in travellers returning from South Asia.
CONCLUSION: Risk-based evaluations of ESBL-PE colonisation should be performed not only for regular tourists but also for long-term business travellers.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Keywords:  ESBL-PE; Japan; Long-term business travellers

Mesh:

Substances:

Year:  2016        PMID: 27769900     DOI: 10.1016/j.tmaid.2016.09.012

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  4 in total

Review 1.  The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread.

Authors:  Fabiana Arieti; Alessia Savoldi; Nithya Babu Rejendran; Marcella Sibani; Maela Tebon; Maria Diletta Pezzani; Anna Gorska; Teresa M Wozniak; Evelina Tacconelli
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

2.  Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors.

Authors:  Anne F Voor In 't Holt; Kees Mourik; Berend Beishuizen; Adriënne S van der Schoor; Annelies Verbon; Margreet C Vos; Juliëtte A Severin
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-20       Impact factor: 4.887

3.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.

Authors:  Tinja Lääveri; Jessica A Vlot; Alje P van Dam; Hanni K Häkkinen; Gerard J B Sonder; Leo G Visser; Anu Kantele
Journal:  BMC Infect Dis       Date:  2018-07-23       Impact factor: 3.090

4.  Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli.

Authors:  Motoyasu Miyazaki; Yota Yamada; Koichi Matsuo; Yukie Komiya; Masanobu Uchiyama; Nobuhiko Nagata; Tohru Takata; Shiro Jimi; Osamu Imakyure
Journal:  J Clin Med Res       Date:  2019-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.